Replies to post #2603 on Enanta Pharmaceuticals Inc (ENTA)

[Gene-e]

They repeated many times that their regulatory path is through a partnership (they’ve done it with ABBV before for HCV). ENTA definitely doesn’t have a bandwidth to run multi-thousand-patient global Phase III studies